Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Obesity is considered a chronic condition and GLP-1 medications are intended for long-term use Evidence shows that stopping the medication often leads to weight regain Many patients remain on therapy indefinitely, similar to treatments for other chronic conditions (e.g., hypertension or diabetes), provided the medication is effective and well tolerated Periodic reassessment ensures the treatment remains appropriate and beneficial GLP-1 Agonists: A Powerful Tool for Sustainable Weight Management One of the most exciting advancements Ive seen in clinical practice is the use of GLP-1 receptor agonists medications that are transforming how we approach obesity and metabolic health
Hims does not require insurance, nor do they accept insurance
When a provider evaluates you for GLP-1 treatment, they often look at: Your current weight and BMI Your weight-loss history and what youve tried before Whether you have diabetes, prediabetes, or insulin resistance Your current medications and medical conditions Your family history and overall risk factors The goal is not just to help you lose weight, but to do it safely and in a way that fits your health profile
What About GLP-3 And Retatrutide
Research Summary GHK-Cu (Glycyl-L-histidyl-L-lysine:copper) is a naturally occurring human plasma tripeptide that declines with age
This creates a natural decrease in calorie intake without harsh or unrealistic measures
